PATENT CLAIM ANALYSIS

Application Number: 16108879
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "250000"]

Abstract:
Methods for treating a subject infected with  Clostridium difficile  comprises administering to the subject a synergistic combination of clofazimine and metronidazole. Pharmaceutical compositions comprising clofazimine and metronidazole are provided for treating  Clostridium difficile  infection and diseases or symptoms associated therewith.

Claim (Index 10):
A method of treating  Clostridium difficile  associated disease or  Clostridium difficile  infection in a subject, comprising administering to the subject a pharmaceutical composition consisting of a clofazimine analogue, at least one pharmaceutically acceptable excipient, and at least one additional antimicrobial agent; wherein the clofazimine analogue is B4154 analogue, B4129 analogue, B4087 analogue, B4165 analogue, B826 analogue, B3640 analogue, B4100 analogue, B4101 analogue, B4021 analogue, B4157 analogue, B746 analogue, or B3987 analogue.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.35484
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15421982', '15831237', '15576220', '15363523', '14888289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7695672622269142
- 35 USC 102 Novelty (BERT): 0.599684005587286
- Combined Prediction Score: 0.7525789365629514
- Mean Citation Score: 347.448196
- Max Citation Score: 643.03735
- Similarity Product: 424.673615530312

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test